Bahl & Gaynor Inc Amgen Inc Transaction History

Bahl & Gaynor Inc

$19.3 Billion
Q3 2024

A detailed history of Bahl & Gaynor Inc transactions in Amgen Inc stock. As of the latest transaction made, Bahl & Gaynor Inc holds 414,270 shares of AMGN stock, worth $110 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

414,270

Previous 574,961 27.95%

Holding current value

$110 Million

Previous $180 Million 25.7%

% of portfolio

0.69%

Previous 1.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $49.7 Million - $54.2 Million	-160,691 Reduced 27.95%	414,270 $133 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $9.94 Million - $12.1 Million	-37,848 Reduced 6.18%	574,961 $180 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $1.67 Million - $2.02 Million	6,229 Added 1.03%	612,809 $174 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $41.2 Million - $46.5 Million	161,157 Added 36.18%	606,580 $175 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $8.64 Million - $10.7 Million	39,519 Added 9.74%	445,423 $120 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $46.8 Million - $55.4 Million	-218,492 Reduced 34.99%	405,904 $90.1 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $46 Million - $56.1 Million	203,909 Added 48.49%	624,396 $151 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $5.9 Million - $7.49 Million	-25,751 Reduced 5.77%	420,487 $110 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $4.94 Million - $5.57 Million	22,016 Added 5.19%	446,238 $101 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $2.4 Million - $2.67 Million	-10,399 Reduced 2.39%	424,222 $103 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $5.07 Million - $5.61 Million	-23,119 Reduced 5.05%	434,621 $105 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $56.5 Million - $64.7 Million	-284,154 Reduced 38.3%	457,740 $103 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $1.88 Million - $2.2 Million	-8,861 Reduced 1.18%	741,894 $158 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $14.3 Million - $15.9 Million	-61,411 Reduced 7.56%	750,755 $183 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $11.6 Million - $13.6 Million	-52,453 Reduced 6.07%	812,166 $202 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $3.41 Million - $4.06 Million	-15,760 Reduced 1.79%	864,619 $199 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $1.12 Million - $1.25 Million	-4,785 Reduced 0.54%	880,379 $224 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $521,229 - $639,619	2,635 Added 0.3%	885,164 $209 Million
Q1 2020 May 26, 2020	BUY	$182.24 - $241.7 $128 Million - $170 Million	705,044 Added 397.24%	882,529 $179 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $127 Million - $168 Million	-695,413 Reduced 79.67%	177,485 $36 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $6.36 Million - $8.17 Million	33,594 Added 4.0%	872,898 $210 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $28.3 Million - $33.9 Million	-162,476 Reduced 16.22%	839,304 $162 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $330,066 - $386,911	-1,980 Reduced 0.2%	1,001,780 $185 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $60.1 Million - $67.7 Million	-332,295 Reduced 24.87%	1,003,760 $191 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $70 Million - $81.7 Million	392,493 Added 41.6%	1,336,055 $260 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $67.1 Million - $75.7 Million	-362,404 Reduced 27.75%	943,562 $196 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $12.6 Million - $14.1 Million	75,664 Added 6.15%	1,305,966 $241 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $10.6 Million - $12.3 Million	-62,328 Reduced 4.82%	1,230,302 $210 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $46 Million - $51.4 Million	272,694 Added 26.74%	1,292,630 $225 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $29.5 Million - $33.7 Million	176,523 Added 20.93%	1,019,936 $190 Million
Q2 2017 Aug 11, 2017	BUY	N/A	49,917 Added 6.29%	843,413 $145 Million
Q2 2017 Aug 10, 2017	BUY	N/A	793,496	793,496 $116 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account